We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First Patient Enrolled in BrainStorm's Phase II ALS Trial

News   Jun 10, 2014

 
First Patient Enrolled in BrainStorm's Phase II ALS Trial
 
 
 

RELATED ARTICLES

T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's disease

News

Researchers in Germany discover a potential new target for treating Parkinson's disease

READ MORE

Doctors Rely on More Than Just Data During a Diagnosis

News

Computer scientists examine how a doctor’s “gut feeling” influences how many tests they order for patients

READ MORE

UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPO

News

MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE